The goal of the trans-network projects is to bring in expertise outside of this PS-OC. If this proposal is successful, then we will immediately begin the work with ether PS-OCs to create mechanisms for developing trans network projects. It is hard to develop these mechanisms with knowing what the other centers will focus on, where they will be, and hew they will be composed. Following the specific NCI guidance (http://physics.cancer.gev/RFA/RFA-CA-09-009-FAQs.asp) and the RFA, we do not propose specific trans-network projects, but rather assert that developing these projects is a key priority for us as a center and we look forward to working with the NCI and our sister PS-OCs to establish a vibrant and scientifically rich set of trans network projects. For example, it will be very important for us to apply our approaches net onlv to breast cancer but also to ether cancers, such as prostate cancer. Ideally, we would thus start a trans-network pilot project with a center focusing en prostate. Part of what we will need to do post-award is to develop processes, mechanisms, and strategies of how trans-network pilot projects will be selected and initiated. We have already discussed approaches for that in our 'within-center'pilot project section. At each opportunity where progress is assessed and plans are discussed, such as at regular meetings of the Executive Committee and the Center Advisory Committee (CAC). and during the Center's annual review, the agenda will include a specific focus on identifying needs for additional areas of expertise, broadening interactions beyond the network, and exposing researchers to alternative and new approaches. Among the benefits of this ongoing dialogue would be the opportunity to identify premising new lines of scientific inquiry that might merit development of new pilots.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-9)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
United States
Zip Code
Damiano, L; Stewart, K M; Cohet, N et al. (2014) Oncogenic targeting of BRM drives malignancy through C/EBP*-dependent induction of *5 integrin. Oncogene 33:2441-53
Veiseh, Mandana; Kwon, Daniel H; Borowsky, Alexander D et al. (2014) Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset. Proc Natl Acad Sci U S A 111:E1731-9
Kim, Yushan; Kumar, Sanjay (2014) CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility. Mol Cancer Res 12:1416-29
Venugopalan, Gautham; Camarillo, David B; Webster, Kevin D et al. (2014) Multicellular architecture of malignant breast epithelia influences mechanics. PLoS One 9:e101955
Shi, Quanming; Ghosh, Rajarshi P; Engelke, Hanna et al. (2014) Rapid disorganization of mechanically interacting systems of mammary acini. Proc Natl Acad Sci U S A 111:658-63
Greene, Adrienne C; Lord, Samuel J; Tian, Aiwei et al. (2014) Spatial organization of EphA2 at the cell-cell interface modulates trans-endocytosis of ephrinA1. Biophys J 106:2196-205
Hines, William C; Su, Ying; Kuhn, Irene et al. (2014) Sorting out the FACS: a devil in the details. Cell Rep 6:779-81
Nickerson, Andrew; Huang, Tao; Lin, Li-Jung et al. (2014) Photoactivated localization microscopy with bimolecular fluorescence complementation (BiFC-PALM) for nanoscale imaging of protein-protein interactions in cells. PLoS One 9:e100589
MacKay, Joanna L; Sood, Anshum; Kumar, Sanjay (2014) Three-dimensional patterning of multiple cell populations through orthogonal genetic control of cell motility. Soft Matter 10:2372-80
Paszek, Matthew J; DuFort, Christopher C; Rossier, Olivier et al. (2014) The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature 511:319-25

Showing the most recent 10 out of 82 publications